MICRO-X LIMITED — Capital/Financing Update 2018

Mar 5, 2018

Micro-X Limited, 1284 South Road, Tonsley, South Australia, 5042

ABN: 21 153 273 735

==> picture [127 x 37] intentionally omitted <==

Tuesday 6[th] March 2018

ASX Announcement – MICRO-X LIMITED (ASX: MX1)

NANO COMMERCIALISATION UPDATE

Further to Micro-X Limited’s (‘ Micro-X’ ) announcement on 26[th] February that the DRX Revolution Nano ( ‘Nano’ ) is now on sale by Carestream Health Inc. (‘ Carestream’) , Micro-X’s global distribution partner, and following a successful exhibition of the Nano at the European Congress of Radiology held in Vienna last week, Micro-X is pleased to announce the receipt of a purchase order this morning for Nano units and spare parts in excess of A$1.8M. These Nano units will be used to support Carestream’s sales and marketing activities and provide initial stock for first customer sales.

“This is a historic moment in Micro-X’s evolution and one which everyone in the Company has been working very hard to achieve” said Peter Rowland, Managing Director. “We are very pleased and excited now to be in production of this fantastic new product”.

For further information please contact:

Mr Peter Rowland Managing Director, Micro-X Limited Telephone: +61 418 844 981 prowland@micro-x.com www.micro-x.com

About Micro-X : Micro-X Limited (“ MX1 ”) is an Australian Securities Exchange listed company developing and commercialising a range of highly innovative products based on proprietary carbon nanotube emitter technologies exclusively licensed and sourced from XinRay Systems Inc., a US based technology developer. These technologies enable the miniaturisation of a number of X-ray applications relevant to large global markets.

The Company has three initial products in its development pipeline – a mobile medical x-ray imager for hospitals, a version for deployed military use and a mobile security back-scatter imager. It is establishing manufacturing for these products in an ISO13485 certified facility in Tonsley, South Australia.